Claudia Tato-Fernández

Claudia Tato-Fernández

Auto-generated profile, based on publicly available information

Claudia Tato-Fernández

Turku PET Centre, University of Turku, Turku University Hospital, Turku, Finland

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2025 in Alzheimer's Research & Therapy
Verified
Journal Article
Open access
PDF file
LFLarissa Fischer
Larissa Fischer
DPDana M Parker
Dana M Parker
SMSamira Maboudian
Samira Maboudian
CFCorrina Fonseca
Corrina Fonseca
CTClaudia Tato-Fernández
Claudia Tato-Fernández
MSMichael Schöll
Michael Schöll
Despite extensive research, open questions about the biological underpinnings of Alzheimer’s disease (AD) remain. Neuroimaging biomarkers based on positron emission tomography (PET) and magnetic resonance imaging (MRI) offer in vivo insights into these complex biological changes and interactions. However, most evidence to date comes from cross-sectional studies, limiting our understanding of disease progression. Longitudinal studies enable the investigation of biological changes within individuals, revealing how pathology evolves over time. With this review, we provide an overview of how longitudinal imaging biomarker studies have advanced the field and how they can contribute to future research. We highlight longitudinal biomarker studies that have provided critical insights into disease trajectories, staging, and individual variability. We further assess longitudinal multimodal studies which have elucidated interactions between AD-specific pathology, amyloid-β and tau, and broader biological changes like neurodegeneration, neuronal dysfunction, vascular disease, and inflammation. Further, we discuss associations of brain changes with symptomatology and clinical outcomes and conclude with challenges and future directions.

15 February 2024 in Neurobiology of Disease
Verified
Journal Article
Open access
CTClaudia Tato-Fernández
Claudia Tato-Fernández
LELaura L. Ekblad
Laura L. Ekblad
EPElina Pietilä
Elina Pietilä
VSVirva Saunavaara
Virva Saunavaara
SHSemi Helin
Semi Helin
ASAnniina Snellman
Anniina Snellman
Except for aging, carrying the APOE ε4 allele (APOE4) is the most important risk factor for sporadic Alzheimer's disease. APOE4 carriers may have reduced capacity to recycle lipids, resulting in white matter microstructural abnormalities. In this study, we evaluated whether white matter impairment measured by diffusion tensor imaging (DTI) differs between healthy individuals with a different number of APOE4 alleles and whether white matter impairment associates with brain beta-amyloid (Aβ) load and serum levels of neurofilament light chain (NfL). We studied 96 participants (APOE3/3, N = 37; APOE3/4, N = 39; APOE4/4, N = 20; mean age 70.7 (SD 5.22) years, 63% females) with a brain MRI including a DTI sequence (N = 96), Aβ-PET (N = 89) and a venous blood sample for the serum NfL concentration measurement (N = 88). Fractional anisotropy (FA), mean diffusivity (MD), radial diffusivity (RD) and axial diffusivity (AxD) in six a priori-selected white matter regions-of-interest (ROIs) were compared between the groups using ANCOVA, with sex and age as covariates. A voxel-weighted average of FA, MD, RD and AxD was calculated for each subject, and correlations with Aβ-PET and NfL levels were evaluated. APOE4/4 carriers exhibited a higher MD and a higher RD in the body of corpus callosum than APOE3/4 (p = 0.0053 and p = 0.0049, respectively) and APOE3/3 (p = 0.026 and p = 0.042). APOE4/4 carriers had a higher AxD than APOE3/4 (p = 0.012) and APOE3/3 (p = 0.040) in the right cingulum adjacent to cingulate cortex. In the total sample, composite MD, RD and AxD positively correlated with the cortical Aβ load (r = 0.26 to 0.33, p < 0.013 for all) and with serum NfL concentrations (r = 0.31 to 0.36, p < 0.0028 for all). In conclusion, increased local diffusivity was detected in cognitively unimpaired APOE4/4 homozygotes compared to APOE3/4 and APOE3/3 carriers and increased diffusivity correlated with biomarkers of Alzheimer's disease and neurodegeneration. White matter impairment seems to be an early phenomenon in the Alzheimer's disease pathologic process in APOE4/4 homozygotes.

9 January 2026 in Alzheimer's Research & Therapy
Verified
Journal Article
Open access
PDF file
JBJulia R. Bacci
Julia R. Bacci
SKStamatia Karagianni
Stamatia Karagianni
ZAZampeta-Sofia Alexopoulou
Zampeta-Sofia Alexopoulou
SMShirine Moukaled
Shirine Moukaled
CTClaudia Tato-Fernández
Claudia Tato-Fernández
RPR W. Paterson
R W. Paterson
Alzheimer’s disease (AD) is the most common neurodegenerative disorder, affecting millions worldwide. The clinical presentation of AD is heterogenous

25 September 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
TKTeemu Kipinoinen
Teemu Kipinoinen
JTJouni Tuisku
Jouni Tuisku
EPElina Pietilä
Elina Pietilä
CTClaudia Tato-Fernandez
Claudia Tato-Fernandez
SHSemi Helin
Semi Helin
LELaura L. Ekblad
Laura L. Ekblad
Neuroinflammation seems to play an important role in the pathological process of Alzheimer’s disease (AD). We hypothesized that neuroinflammation is associated with beta-amyloid (Aβ) accumulation longitudinally in preclinical AD. We performed a 5-year follow-up study with TSPO positron emission tomography (PET) and Aβ PET both at baseline and at follow-up. Altogether 40 healthy older adults without dementia or cognitive impairment at baseline (median age at follow-up 74.8 (interquartile range 73.4 to 77.2; 55% women; 50% APOEε4 carriers) were examined in 2014-2016 and 2019-2021 with [11C]PBR28-PET to measure neuroinflammation and [11C]PiB-PET to measure Aβ. [11C]PBR28 and [11C]PiB standardized uptake value ratios (SUVr) were quantified for a cortical composite region using cerebellar grey matter as the reference region. Associations between [11C]PBR28 and [11C]PiB SUVr at baseline and follow-up, and the change in [11C]PBR28 and [11C]PiB SUVr during the follow-up were analysed with linear models adjusted for age, sex and TSPO genotype. The analyses were also stratified by baseline Aβ-positivity (cut-off for positivity [11C]PiB SUVR=1.5). An increase in neuroinflammation ([11C]PBR28 SUVr) was associated with an increase in Aβ accumulation during the 5-year follow-up in the total study population (β=2.95, P=0.002), and in Aβ positive (β=2.89, P=0.04) and negative (β=1.71, P=0.04) individuals. Baseline neuroinflammation did not predict follow-up Aβ binding (β=0.74, P=0.71), or the change in Aβ accumulation during the follow-up (β=0.35, P=0.74) in the total study population. Our results suggest that neuroinflammation associated with Aβ accumulation in older individuals regardless of their Aβ status and that neuroinflammation may drive Aβ accumulation in aging.

28 October 2023 in medRxiv
Verified
Preprint
Open access
PDF file
CTClaudia Tato-Fernández
Claudia Tato-Fernández
LELaura L. Ekblad
Laura L. Ekblad
EPElina Pietilä
Elina Pietilä
VSVirva Saunavaara
Virva Saunavaara
SHSemi Helin
Semi Helin
ASAnniina Snellman
Anniina Snellman
Except for aging, APOE ε4 allele ( APOE4 ) is the most important risk factor for sporadic Alzheimer’s disease. APOE4 carriers may have reduced capacity to recycle lipids, resulting in reduced white matter integrity. Here, we evaluated if white matter impairment measured by diffusion tensor imaging (DTI) differs between healthy individuals with different number of APOE4 alleles and if white matter impairment associates with brain beta-amyloid (Aβ) load and serum levels of neurofilament light chain (NfL). We studied 96 participants ( APOE4/4 , N = 20; APOE4/3 , N = 39; APOE3/3 , N = 37; mean age 70.7 (SD 5.22) years, 63% females) with brain MRI including a DTI sequence (N = 96), Aβ-PET (N = 89) and a venous blood sample for serum NfL concentration measurement (N = 88). Fractional anisotropy (FA), mean diffusivity (MD), radial diffusivity (RD) and axial diffusivity (AxD) in six a priori -selected white matter regions-of-interest (ROIs) were compared between the groups using ANCOVA, with sex and age as covariates. A voxel-weighted average of FA, MD, RD and AxD was calculated for each subject, and correlations with Aβ-PET and NfL levels were evaluated. APOE4/4 carriers exhibited higher MD and higher RD in the body of corpus callosum than APOE4/3 (p = 0.0053 and p = 0.0049, respectively) and APOE3/3 (p = 0.026 and p = 0.042). APOE4/4 carriers had higher AxD than APOE4/3 (p = 0.012) and APOE3/3 (p = 0.040) in the right cingulum adjacent to cingulate cortex. In the total sample, composite MD, RD and AxD positively correlated with cortical Aβ load (r = 0.26 to 0.33, p < 0.013 for all) and with serum NfL concentrations (r = 0.31 to 0.36, p < 0.0028 for all). In conclusion, reduced white matter integrity was detected in cognitively unimpaired APOE4/4 homozygotes compared to APOE4/3 and APOE3/3 carriers and reduced white matter integrity correlated with biomarkers of Alzheimer’s disease and neurodegeneration. White matter impairment seems to be an early phenomenon in the Alzheimer’s disease pathologic process in APOE4/4 homozygotes. Highlights: Cognitively normal elderly APOE4 homozygotes showed impaired white matter integrity APOE4 homozygotes showed higher diffusivity in corpus callosum and right cingulum MD, RD and AxD correlate with amyloid load assessed by PET in APOE4 carriers MD, RD and AxD correlate with serum neurofilament light chain in APOE4 carriers White matter impairment may be an early phenomenon in the AD pathologic process